CFO of Array BioPharma Inc. (ARRY, Financial) Michael Carruthers sells 5,681 shares of ARRY on 01/06/2010 at an average price of $2.69 a share.
Array Biopharma Inc. has a market cap of $127.7 million; its shares were traded at around $2.59 with and P/S ratio of 5.1. Array Biopharma Inc. had an annual average earning growth of 32.7% over the past 5 years.
ARRY is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Array Biopharma Inc. has a market cap of $127.7 million; its shares were traded at around $2.59 with and P/S ratio of 5.1. Array Biopharma Inc. had an annual average earning growth of 32.7% over the past 5 years.
ARRY is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
CFO Recent Trades:
- Sell:: CFO Michael Carruthers sold 1,533 shares of ARRY stock on 12/23/2009 at the average price of 2.66, the price of the stock has decreased by 2.63% since.
- Sell:: CFO Michael Carruthers sold 2,045 shares of ARRY stock on 11/23/2009 at the average price of 2.01, the price of the stock has increased by 28.86% since.
- Sell:: CFO Michael Carruthers sold 2,049 shares of ARRY stock on 10/23/2009 at the average price of 2.01, the price of the stock has increased by 28.86% since.
- Sell:: CFO Michael Carruthers sold 1,315 shares of ARRY stock on 09/25/2009 at the average price of 2.77, the price of the stock has decreased by 6.5% since.
- Sell:: CFO Michael Carruthers sold 882 shares of ARRY stock on 08/24/2009 at the average price of 4.17, the price of the stock has decreased by 37.89% since.
